| Sun Pharmaceuticals Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524715 |
NSE Symbol : SUNPHARMA |
P/E(TTM) : 157.19 |
|
ISIN Demat : INE044A01036 |
Div & Yield% : 0.74 |
EPS(TTM) : 11.60 |
|
Book Value(₹) : 98.75 |
Market Cap(₹Cr) : 437,482.74 |
Face Value(₹) : 1.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 20,275.17 | 20,812.14 | 15,585.98 | 14,116.05 | 12,531.93 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 20,275.17 | 20,812.14 | 15,585.98 | 14,116.05 | 12,531.93 |
| Other Income | 553.48 | 329.29 | 1,196.88 | 192.07 | 1,510.92 |
| Stock Adjustments | -180.32 | 237.93 | 183.18 | 179.64 | -138.60 |
| Total Income | 20,648.33 | 21,379.36 | 16,966.04 | 14,487.76 | 13,904.25 |
| EXPENDITURE : | |||||
| Raw Materials | 5,423.79 | 6,292.09 | 5,833.57 | 5,287.12 | 4,429.12 |
| Power and Fuel Cost | 450.42 | 495.21 | 422.33 | 384.16 | 394.74 |
| Other Manufacturing Expenses | 1,195.30 | 1,037.32 | 1,064.32 | 862.12 | 860.05 |
| Selling and Administration Expenses | 4,754.86 | 4,326.42 | 3,514.05 | 3,309.62 | 1,919.25 |
| Miscellaneous Expenses | 615.66 | 3,257.27 | 2,086.08 | 479.24 | 375.75 |
| Employee Benefit Expenses | 2,373.95 | 2,156.95 | 2,000.78 | 1,805.98 | 1,702.77 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 5,834.35 | 3,814.10 | 2,044.91 | 2,359.52 | 4,222.57 |
| Interest | 784.08 | 472.18 | 388.10 | 267.52 | 408.01 |
| Gross Profit | 5,050.27 | 3,341.92 | 1,656.81 | 2,092.00 | 3,814.56 |
| Depreciation | 1,600.62 | 1,600.87 | 1,349.95 | 1,236.43 | 561.56 |
| Profit Before Tax | 3,449.65 | 1,741.05 | 306.86 | 855.57 | 3,253.00 |
| Current Tax | 546.10 | 752.77 | -553.58 | 244.91 | 386.46 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 45.37 | -702.44 | 960.43 | -231.74 | -344.60 |
| Reported Net Profit | 2,858.18 | 1,690.72 | -99.99 | 842.40 | 3,211.14 |
| Extraordinary Items | -193.46 | -1,665.67 | 1,237.51 | -63.64 | 193.27 |
| Adjusted Net Profit | 3,051.64 | 3,356.39 | -1,337.50 | 906.04 | 3,017.87 |
| Adjustment below Net Profit | -19.86 | 7.38 | -14.53 | 2,675.94 | -211.52 |
| Profit/Loss Balance carried down | 12,790.88 | 13,612.08 | 15,964.55 | 14,005.27 | 12,384.61 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 2,898.16 | 2,519.30 | 2,237.95 | 1,559.06 | 1,378.96 |
| P & L Balance carried down | 12,731.04 | 12,790.88 | 13,612.08 | 15,964.55 | 14,005.27 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 1,350.00 | 1,150.00 | 1,000.00 | 750.00 | 400.00 |
| Dividend Per Share(Rs) | 13.50 | 11.50 | 10.00 | 7.50 | 4.00 |
| Earnings Per Share-Unit Curr | 11.91 | 7.05 | -0.42 | 3.51 | 13.38 |
| Earnings Per Share(Adj)-Unit Curr | 11.91 | 7.05 | -0.42 | 3.51 | 13.38 |
| Book Value | 98.76 | 98.98 | 102.48 | 112.28 | 101.68 |
| Book Value(Adj)-Unit Curr | 98.76 | 98.98 | 102.48 | 112.28 | 101.68 |